Denise L. Blomquist - 26 May 2026 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: Chief Accounting Officer
Issuer ticker: MDT
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 16:24:20 UTC
Prior SEC filing: 29 Apr 2026
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Denise L. Blomquist filed Form 4 for Medtronic plc (MDT) on 28 May 2026.

Key facts

This page summarizes Denise L. Blomquist's Form 4 filing for Medtronic plc (MDT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 May 2026, 16:24.

Change

Previous filing in this sequence was filed on 29 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061393 Primary reporting owner

Blomquist Denise L.

Relationship: Chief Accounting Officer
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +1,712
Change %: +13%
Price: $0.000000^*
Shares after: 14,974
Date: 26 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Unit

Options Exercise

Transaction value
Shares: -1,621
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 26 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,621
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends.

Footnote F2

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F3

The performance share units vested on April 24, 2026.